Your Professional API Suppliers

 

 

Xi'an Greennee Biological Technology Co., Ltd is a professional herb extract company, integrating research and development, production and sales and herb extract inspection instrument equipment and accessories sales.

 

Why Choose Us
 

Our Product
We Herb extract,Health product raw materials,cosmetic raw materials,pharmaceutical intermediates,Raw material medicine,instrument, digital panel meter and so on.

 

Quality Assurance
We can help the customer to confirm the products according to customers need. Fast delivery sample. We promise the quality is the first.

 

Sales Market
We are sale the hundred of type products to many countries. Main country is America, European, Australia and so on. We have many experiences of produce and export over 20 years.

 

Certificates
Our company has obtained ISO 14001, ISO 45001 and ISO 9001 management system, and we have passed the official GMP inspection and certification of the State Food and Drug Administration, the US FDA, the European Union EDQM, Brazil ANVISA, South Korea KFDA, Mexico Cofepris and other official GMP inspection certifications.

Lorlatinib

 

What is Lorlatinib

Lorlatinib is a kinase inhibitor for oral administration used to treat cancer. A kinase inhibitor is an enzyme inhibitor that can block the action of protein kinases.

 

 

How To Take Lorlatinib

Lorlatinib is taken orally, in the form of tablets. Lorlatinib may be taken with or without food. The drug should be swallowed whole, without chewing, crushing or breaking the tablet. You should take this medicine at the same time each day. If you miss a dose, take it as soon as you remember unless it is less than 4 hours until the next dose. Do not take 2 doses at the same time to make up for a missed dose.

When using the drug, you need to limit the use of some foods, including: Grapefruit, grapefruit juice, Ketoconazole, Rifampin, Phenytoin, St. John's wort and Fentanyl. Also, tell your treating doctor about all other medicines and supplements you are taking.

L-leucine

 

What Is The Mechanism Of Lorlatinib
 

Lorlatinib is a targeted therapy drug commonly used in the treatment of non-small cell lung cancer (NSCLC). It specifically caters to patients whose tumors possess certain genetic alterations in the anaplastic lymphoma kinase (ALK) gene or the c-ros oncogene 1 (ROS1) gene.

 

At the molecular level, Lorlatinib functions as a tyrosine kinase inhibitor (TKI). Tyrosine kinases are enzymes responsible for the activation of many proteins by signaling cellular pathways through the addition of a phosphate group to tyrosine residues on target proteins.

 

Lorlatinib binds to the ATP-binding pocket of the aberrant ALK and ROS1 tyrosine kinases, inhibiting their activity. By doing so, it effectively halts the phosphorylation process that is crucial for the activation of the downstream signaling cascades.

 

The mechanism of Lorlatinib involves the selective inhibition of aberrant ALK and ROS1 tyrosine kinases, resulting in the disruption of critical signaling pathways essential for cancer cell survival and proliferation. Its ability to cross the blood-brain barrier enhances its therapeutic efficacy, particularly in patients with brain metastases.

 

Types of API

 

productcate-500-500

Cabozantinib S-Malate

Cabozantinib S-malate is an effective multi receptor tyrosine kinase inhibitor with IC50 values of 0.035, 1.3, 4.6, 7, and 11.3 nM, respectively, for inhibiting VEGFR2, c-Met, Kit, Axl, and Flt3.

productcate-1-1

Brigatinib

Brigatinib is a anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma enzyme positive metastatic non-small cell lung cancer.

productcate-1-1

Capmatinib Hydrochloride Hydrate

Capmatinib Hydrochloride Hydrate(INCB28060)is a potent, oral, selective, ATP competitive c-Met kinase inhibitor (IC50=0.13nM).

 

Crizotinib

 

What is Crizotinib

Crizotinib is a kinase inhibitor that works by targeting and blocking receptors found on cancer cells called nonproducing lymphoma kinase (ALK). Crizotinib is used to treat lung cancer that has spread to other parts of the body.

 

 

How To Use Crizotinib

Crizotinib is taken orally, can be taken with food. The patient should swallow the tablet whole with water, do not break, open, crush or chew the tablet.
Dosage of Crizotinib for adults with lung cancer: 250mg x 2 times/day.
Currently, the dose of Crizotinib for children has not been studied and decided. So consult your doctor before giving Crizotinib to a child.
If you forget to take a dose of Crizotinib, take it as soon as you remember. However, if it is almost time for your next dose of Crizotinib, skip the missed dose and take your next dose exactly as directed by your doctor. Never take a double dose of Crizotinib to make up for a missed dose.

Brigatinib Related Intermediates

 

Precautions of Crizotinib
 
 

Caution should be exercised in patients with history of liver or kidney disease, vision problems, abnormal heart rhythm, prolonged QT syndrome, electrolyte imbalance, who are taking other medications, any allergy, during pregnancy and breastfeeding.

 
 

It may cause dizziness, drowsiness, or blurred vision, do not drive a car or operate machinery while taking this medication.

 
 

It may reduce platelet counts; avoid injury or bruising.

 
 

Avoid contact with people who have infections that may spread to others.

 
 

Rarely patient may develop with fatal inflammation of the lungs (pneumonitis) with the following symptoms: trouble in breathing, shortness of breath, cough, or fever. If it is so consult with your healthcare provider immediately.

 

 

 
What Is The Mechanism Of Crizotinib
 
01/

Crizotinib is a targeted cancer therapy primarily used for the treatment of non-small cell lung cancer (NSCLC) that harbors specific genetic alterations.

02/

At the core of Crizotinib's mechanism is its inhibition of the anaplastic lymphoma kinase (ALK) protein. ALK is a receptor tyrosine kinase, which means it is involved in the signaling pathways that regulate cell growth and survival.

03/

One of the most common ALK gene rearrangements in involves the fusion of the ALK gene with the EML4 gene, resulting in the EML4-ALK fusion protein. This fusion protein is constitutively active, meaning it is always "on," sending continuous signals for the cancer cells to grow and divide.

04/

Crizotinib functions as an ALK inhibitor. By binding to the ATP-binding site of the ALK protein, Crizotinib blocks its kinase activity. This inhibition prevents the phosphorylation of downstream signaling molecules that are necessary for the cancer cells to proliferate and survive.

 

FAQ
 

Q: What is crizotinib used for?

A: Crizotinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that is caused by a defect in either a gene called anaplastic lymphoma kinase (ALK) or a gene called ROS1. Your doctor will test for the presence of this gene.

Q: Is crizotinib better than chemotherapy?

A: As compared with standard second-line chemotherapy, treatment with crizotinib resulted in significantly longer progression-free survival, significantly higher response rates, a significant reduction in symptoms, and a significant improvement in global quality of life.

Q: What are the benefits of crizotinib?

A: CRIZOTINIB (kriz OH ti nib) treats non-small cell lung cancer. It may also treat anaplastic large-cell lymphoma. It can also be used to treat inflammatory myofibroblastic tumor. It works by slowing down the growth of cancer cells.

Q: How long can you take crizotinib?

A: You usually take crizotinib for as long as it is working and the side effects aren't too bad.

Q: How effective is crizotinib?

A: Progression-free survival was more than twice as long in patients treated with crizotinib than in those who received chemotherapy: 7.7 months versus 3 months. Substantially more patients treated with crizotinib had a tumor response than patients treated with chemotherapy: 65 percent versus 20 percent.

Q: What is lorlatinib used for?

A: Lorlatinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will perform a test to check for the ALK gene before you use this medicine.

Q: How effective is lorlatinib?

A: Lorlatinib has been shown to elicit higher response rates in patients with an ALK resistance mutation detectable by plasma or tissue testing at the time of progression (62%-67% vs. 32%-27% in patients without a detectable ALK resistance mutation) who previously received 1 or more second-generation ALK-TKIs.

Q: What are the precautions for lorlatinib?

A: If you are male, you and your female partner should use birth control during your treatment and for 3 months after your final dose. Talk to your doctor about birth control methods that you can use during your treatment. If you or your partner become pregnant while taking lorlatinib, call your doctor immediately.

As one of the leading api manufacturers and suppliers in China, we warmly welcome you to buy bulk api in stock here from our factory. All customized products are with high quality and competitive price. For quotation, contact us now.

Lorlatinib, Capmatinib Hydrochloride Hydrate, Brigatinib

Shopping Bags